![]() |
||||||
![]() |
||||||
| LEARN ALL ABOUT IT Cancer Crusade: A USC Roadmap In 1973, the National Cancer Institute named the USC/Norris Cancer Center one of the first eight comprehensive cancer centers in the country. Today, there are 40 such cancer centers in the nation. Comprehensive centers differ from other medical institutions in their multidisciplinary approach to research, patient care, prevention and outreach. Researchers work hand in hand with clinicians to provide state-of-the-art care and, when appropriate, enroll cancer patients in ongoing clinical trials (nearly 200 are now in progress at the USC/Norris). This laboratory bench-to-bedside structure means that patients have access to breakthrough treatments not yet available elsewhere. The USC/Norris treats all cancers, but it has particular expertise in cancers of the bladder, prostate, kidney, testis, female reproductive system, breast, lung, gastrointestinal tract, skin, leukemia and lymphomas, and AIDS-related cancers. Researchers and clinicians alike including surgeons, medical specialists, oncologists and radiologists hold faculty positions in the Keck School of Medicine of USC. The mix has spawned intriguing collaborations, such as the joint program in gene therapy with the Keck Schools Institute for Genetic Medicine.
USC/Norris physicians, epidemiologists and statisticians also head up major Keck School demographic studies such as the Cancer Surveillance Program, which compiles information on all new cancer cases more than 30,000 a year reported in Los Angeles County; and the Hawaii/Los Angeles Multiethnic Cohort Study, which looks at diet, ethnicity and environment as potential long-term factors in cancer risk among 215,000 Americans.
|
||||||
|
||||||
|
Features -- Cancer - Got Culture? - The Astonishing LAGQ Departments -- Mailbag - What's New - In Support - Alumni News - The Last Word |
||||||